20-Hydroxyeicosatetraenoic acid (20-HETE) stimulates migration of vascular smooth muscle cells

scientific article published on January 2007

20-Hydroxyeicosatetraenoic acid (20-HETE) stimulates migration of vascular smooth muscle cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1159/000099200
P698PubMed publication ID17310106

P2093author name stringHeather A Drummond
David E Stec
Kimberly P Gannon
Janis S Beaird
P2860cites workInhibitors of cytochrome P450 4A suppress angiogenic responsesQ35083648
Evidence for a membrane site of action for 14,15-EET on expression of aromatase in vascular smooth muscleQ44183007
P433issue1-4
P304page(s)121-128
P577publication date2007-01-01
P1433published inCellular Physiology and BiochemistryQ2229420
P1476title20-Hydroxyeicosatetraenoic acid (20-HETE) stimulates migration of vascular smooth muscle cells
P478volume19

Reverse relations

cites work (P2860)
Q2828894220-HETE and blood pressure regulation: clinical implications
Q3599153920-HETE contributes to ischemia-induced angiogenesis
Q9050332820-HETE in the regulation of vascular and cardiac function
Q3714250320-HETE induces remodeling of renal resistance arteries independent of blood pressure elevation in hypertension
Q3690259120-HETE-induced mitochondrial superoxide production and inflammatory phenotype in vascular smooth muscle is prevented by glucose-6-phosphate dehydrogenase inhibition
Q3434372320-Hydroxyeicosatetraenoic acid inhibition attenuates balloon injury-induced neointima formation and vascular remodeling in rat carotid arteries
Q3357491720-hydroxy-5,8,11,14-eicosatetraenoic acid mediates endothelial dysfunction via IkappaB kinase-dependent endothelial nitric-oxide synthase uncoupling
Q28571898Angiotensin II-induced vascular smooth muscle cell migration and growth are mediated by cytochrome P450 1B1-dependent superoxide generation
Q92512924CYP1B1: A key regulator of redox homeostasis
Q89051959Conflicting roles of 20-HETE in hypertension and renal end organ damage
Q36744134Cyclooxygenase-2 dependent metabolism of 20-HETE increases adiposity and adipocyte enlargement in mesenchymal stem cell-derived adipocytes
Q34157216Cytochrome P450 1B1 contributes to angiotensin II-induced hypertension and associated pathophysiology
Q28396302Cytochrome P450 eicosanoids and cerebral vascular function
Q34152658Cytochrome P450 ω-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer
Q44362268Differential expression of cytochrome P450 omega-hydroxylase isoforms and their association with clinicopathological features in pancreatic ductal adenocarcinoma.
Q42115749Induction of angiotensin-converting enzyme and activation of the renin-angiotensin system contribute to 20-hydroxyeicosatetraenoic acid-mediated endothelial dysfunction.
Q37138134Intravenous formulation of N-hydroxy-N'-(4-n-butyl-2-methylphenyl)formamidine (HET0016) for inhibition of rat brain 20-hydroxyeicosatetraenoic acid formation
Q35787438Involvement of cytochrome P-450 1B1 in renal dysfunction, injury, and inflammation associated with angiotensin II-induced hypertension in rats
Q39000644Microsomal cytochrome P450 as a target for drug discovery and repurposing
Q37340856Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology
Q37439758Rapid, simultaneous quantitation of mono and dioxygenated metabolites of arachidonic acid in human CSF and rat brain
Q38100223Role of cytochrome P450-mediated arachidonic acid metabolites in the pathogenesis of cardiac hypertrophy.
Q34338086Targeting 20-HETE producing enzymes in cancer - rationale, pharmacology, and clinical potential

Search more.